Lupin incorporates unit in US to focus on oncology products

Drug maker Lupin on Tuesday said it has incorporated a wholly-owned subsidiary in the US.

migrator

Updated:21st Apr, 2021 at 9:47 AM

New Delhi

The new unit, Lupin Oncology Inc (LOI), will be engaged in development/co-development and commercialisation of multiple oncology products globally, the Mumbai-based company said in a regulatory filing.

Lupin has a sizable presence in the US market, the world's biggest market for pharma products.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Lupin incorporates unit in US to focus on oncology products

Drug maker Lupin on Tuesday said it has incorporated a wholly-owned subsidiary in the US.

Also Read

Don’t panic over gas cylinders, CM Stalin appeals to public

Coimbatore: Three staff suspended after 44 kids fall ill post eating noon meal

Vijay’s Jana Nayagan OTT rights reportedly cancelled amid censor row

Mobile, internet services likely to be affected amid LPG crisis triggered by West Asia war

Opposition lambasts Tamil Nadu government over string of crimes against women